Showing results (161-170 of 169) with videos related to
Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 169 results.
Archives of Disease in Childhood|January 1, 1986
C reactive protein in the evaluation of febrile illnessA Putto, O Ruuskanen, O Meurman, et al.Biomed Research International|April 2, 2014
Decreased thioredoxin-1 and increased HSP90 expression in skeletal muscle in subjects with type 2 diabetes or impaired glucose toleranceM Venojärvi, A Korkmaz, S Aunola, et al.Bulletin of the World Health Organization|January 1, 1984
Viral diagnoses using the rapid immunofluorescence technique and epidemiological implications of acute respiratory infections among children in different European countriesI Orstavik, M Grandien, P Halonen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 1997
p53 expression and cell proliferation as prognostic factors in laryngeal squamous cell carcinomaP Hirvikoski, E Kumpulainen, J Virtaniemi, et al.Biochemistry|June 24, 1997
Structural and functional consequences of substitutions at the tyrosine 55-lysine 104 hydrogen bond in Escherichia coli inorganic pyrophosphataseI P Fabrichniy, V N Kasho, T Hyytiä, et al.The British Journal of Surgery|March 22, 2021
Centralized repeated resectability assessment of patients with colorectal liver metastases during first-line treatment: prospective studyH Isoniemi, A Uutela, A Nordin, et al.Gut|April 16, 2005
The C/C-13910 genotype of adult-type hypolactasia is associated with an increased risk of colorectal cancer in the Finnish populationH Rasinperä, C Forsblom, N S Enattah, et al.ESMO Open|July 29, 2021
Treatment response of colorectal cancer liver metastases to neoadjuvant or conversion therapy: a prospective multicentre follow-up study using MRI, diffusion-weighted imaging and 1H-MR spectroscopy compared with histology (subgroup in the RAXO trial)A Uutela, A Ovissi, A Hakkarainen, et al.ESMO Open|July 7, 2022
Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort studyP Osterlund, S Kinos, P Pfeiffer, et al.Pageof 17